Dr. Sireesha Kolachalama, MD

Dr. Kolachalama practices at The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD in Needham, Massachusetts.

Dr. Kolachalama's NPI, 1154494110, was assigned on November 16, 2006. Dr. Kolachalama graduated from Osmania Medical College NTR UHS in 2000. Dr. Kolachalama's Rhode Island license number on file is MD12206.

Dr. Kolachalama's primary practice is The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD, at 148 Chestnut St, Needham, MA 02492.

Dr. Kolachalama's primary practice is The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD in Needham, Massachusetts. Dr. Kolachalama is also affiliated with Beth Israel Deaconess Hospital-Needham. The medical group on file is Beth Israel Deaconess Healthcare. Dmand AI also links Dr. Kolachalama to 4 more hospitals, 3 group practices and clinics, 3 home health agencies and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kolachalama practices, 12 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kolachalama's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kolachalama is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kolachalama's licenses on file in 3 states: Rhode Island, Massachusetts and Texas.

Dmand AI lists acid reflux, aneurysm, anxiety, atrial fibrillation and flutter, chronic diabetes, chronic hypertension, chronic inflammatory bowel disease (IBD) and chronic kidney disease among the conditions Dr. Kolachalama treats.

CMS data shows 1,645 Medicare services from Dr. Kolachalama across 16 procedure codes in 2024, for 289 Medicare patients. Medicare paid $102,065 for them. Every service was in an office.

CMS counts 289 Medicare patients who saw Dr. Kolachalama in 2024. The largest group is 65 to 74, with 110 patients. 71% of them have high blood pressure, and 64% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kolachalama's median patient age at 60, with 52% women.

In 2024, Dr. Kolachalama wrote 4,234 Medicare Part D claims for 433 patients. 90% of them were for generic drugs. CMS names the drug for 3,653 of them, across 82 drugs with 11 or more claims each, at $282,114 in total drug cost. In 2023, CMS named 523 claims across 23 drugs.

Dr. Kolachalama accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kolachalama as offering telehealth.

CMS Open Payments shows 8 general payments to Dr. Kolachalama from 4 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $80.

Dr. Kolachalama graduated from Osmania Medical College NTR UHS in 2000.

Dr. Kolachalama is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.